High Sensitive C-Reactive Protein Serum Levels in Patients with Acute Coronary Syndrome

Document Type : Original Article (s)

Authors

1 Assistant Professor, Department of Cardiology, School of Medicine, Islamic Azad University, Najaf Abad Branch, Isfahan, Iran

2 Resident, Department of Cardiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

3 General Practitioner, Islamic Azad University, Najaf Abad Branch, Isfahan, Iran

4 Department of Clinical Laboratory, Shariati Hospital Laboratory, Social Security Organization, Isfahan, Iran

Abstract

Background: Although high sensitive C-reactive protein (HS CRP) is a predictive factor for acute coronary syndrome, there is controversy about its predictive power. Therefore, it is known as a novel risk factor for coronary artery diseases.Methods: A descriptive, analytic study was performed on 80 patients with acute coronary syndrome. A checklist including demographics, risk factors and the existence of myocardial infarction was completed for all patients. SPSS17 was used to analyze the collected data.Findings: A total number of 30 patients with unstable angina and 25 patients with ST elevated myocardial infarction (STEMI) and non-ST elevated myocardial infarction (NSTEMI) were included the study. Mean CRP values were evaluated in all three groups. There were significant differences between the groups (P < 0.05). The mean ± SD in unstable angina, STEMI and NSTMEI groups were 1.5 ± 0.96, 4.87 ± 1.91 and 2.6 ±1.8, respectively. Conclusion: This study showed CRP to be a risk factor for predicting cardiac incidences. In addition, it is of high value in predicting acute coronary syndrome.

Keywords

References

  1. Scheller B, Hennen B, Hammer B, Walle J, Hofer C, Hilpert V, et al. Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. J Am Coll Cardiol 2003; 42(4): 634-41.
  2. Smith SC, Jr., Feldman TE, Hirshfeld JW, Jr., Jacobs AK, Kern MJ, King SB, III, et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006; 47(1): 216-35.
  3. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 1999; 341(9): 625-34.
  4. Berger PB, Holmes DR, Jr., Stebbins AL, Bates ER, Califf RM, Topol EJ. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study. Circulation 1997; 96(1): 122-7.
  5. Yun KH, Jeong MH, Oh SK, Rhee SJ, Park EM, Lee EM, et al. Response of high-sensitivity C-reactive protein to percutaneous coronary intervention in patients with acute coronary syndrome. Heart Vessels 2009; 24(3): 175-80.
  6. Mockel M, Danne O, Muller R, Vollert JO, Muller C, Lueders C, et al. Development of an optimized multimarker strategy for early risk assessment of patients with acute coronary syndromes. Clin Chim Acta 2008; 393(2): 103-9.
  7. Roubille F, Cayla G, Picot MC, Pradet V, Massin F, Gervasoni R, et al. C-reactive protein (CRP) after revascularized STEMI: is CRP a prognostic factor? Rev Med Interne 2008; 29(11): 868-74.
  8. Kralisz P, Kemona H, Dobrzycki S, Bachorzewska-Gajewska H, Nowak K, Sawicki Z. Changes in C-reactive protein levels following coronary stent implantation depend on the extent of periprocedural arterial injury. Kardiol Pol 2006; 64(4): 364-71.
  9. Worthley SG, Farouque HM, Cameron JD, Meredith IT. Arterial remodeling correlates positively with serological evidence of inflammation in patients with chronic stable angina pectoris. J Invasive Cardiol 2006; 18(1): 28-31.
  10. Tataru MC, Heinrich J, Junker R, Schulte H, von Eckardstein A, Assmann G, et al. C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris. Eur Heart J 2000; 21(12): 1000-8.
  11. Nurkic J, Nurkic M, Nurkic M. High sensitivity C reactive protein and lipid status as a risk factors for coronary disease. Med Arh 2007; 61(3): 138-4.
Journal of Isfahan Medical School
Volume 29, Issue 168 - Serial Number 168
November and December 2012
Pages 2484-2490

Files

History

  • Receive Date: 24 April 2011
  • Revise Date: 02 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics